MEIHUI MENG: Open Payments
NPI 1205546082 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 22 payments from 4 companies in 2025. Trend: 2023 $944 · 2024 $1,244 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $212 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: XIFAXAN, LINZESS, CREON, Kerendia, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
